Detection method of disease presenting insulin resistance disease state

摘要

The present invention provides a convenient method for detecting a disease state of a type 2 diabetes mellitus. The present invention provides a method of detecting insulin resistant disease, particularly type 2 diabetes, including quantifying ganglioside GM3 in blood samples isolated from living organisms. More specifically, (a) separating the plasma or serum from the collected human blood, (b) quantifying the ganglioside GM3 in the isolated plasma or serum, and (c) the average G3 dose in the blood sample of healthy subjects Problem to be solved: to provide a method of detecting an insulin resistance disease including the process of comparing with the triglyceride GM3 quantity, especially type 2 diabetes.